Screening Sexually Active Adolescents for Chlamydia trachomatis : What About the Boys?
Kathleen P. Tebb, PhD,
Robert H. Pantell, MD,
Charles J. Wibbelsman, MD,
John M. Neuhaus, PhD,
Ann C. Tipton, MD,
Samantha C. Pecson, BS,
Meaghan Pai-Dhungat, BS,
Timothy H. Ko, DrPH, MPH and
Mary-Ann B. Shafer, MD
Kathleen P. Tebb, Samantha C. Pecson, Meaghan Pai-Dhungat, and Mary-Ann B. Shafer are with the Division of Adolescent Medicine, Department of Pediatrics, University of California, San Francisco. Robert H. Pantell is with the Department of Pediatrics, University of California, San Francisco. Charles J. Wibbelsman is with Kaiser Permanente, San Francisco. John M. Neuhaus is with the Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco. Ann C. Tipton and Timothy H. Ko are with Kaiser Permanente, Oakland, Calif.
FIGURE 1—Urine-based Chlamydia trachomatis screening rates among sexually active male adolescents.
Note. Error bars indicate 95% confidence intervals. Participants were categorized as sexually active by means of an anonymous survey conducted after their routine checkups.